1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Singapore Pharmaceutical Industry 2H12

Singapore Pharmaceutical Industry 2H12

  • March 2013
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 30 pages

Summary

Table of Contents

Search Inside

Singapore: Pharmaceutical covers the sector overview, sector size, competitive landscape, enviromental scanning, and recent industry developments for Singapore. It also covers the market trends and outlook, key economic indicators, production index, export and import, value added by the sector, human resources, cost of operation and capital expenditure, plus the profile, comparative matrix and SWOT analysis of the industry leading players: Luye Pharma Group Limited, Star Pharmaceuticals Limited, and Pharmesis International Limited.

Over the last decade, Singapore has established itself as the manufacturing hub for leading pharmaceutical companies in Asia. The country’s manufacturing output of pharmaceuticals and biological products grew at an impressive compounded annual growth rate (CAGR) of 15.8% over the 10-year period from 2001 to 2011. During the same period, the economic environment in Singapore had an average GDP growth rate of 6.3% per year.

The report includes the market trends and outlook of the pharmaceutical industry in Singapore. We examine the exports and imports of pharmaceutical products, key economic indicators, production index, value-added by sector, human resources, cost of operation, capital expenditure and government initiatives. Pharmaceutical sector contributed approximately 19.3% to the overall value added of the manufacturing industries. The sector only trailed electronic products sector in terms of value addition.

Also, the report encompasses the profile of leading players in the pharmaceutical industry as well as their respective financial highlights and SWOT analysis. Among the leading pharmaceutical players in Singapore are Luye Pharma Group Limited, Star Pharmaceuticals Limited and Pharmesis International Limited.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.